• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于眼科药物递送的凝胶基材料。

Gel-Based Materials for Ophthalmic Drug Delivery.

作者信息

Cassano Roberta, Di Gioia Maria Luisa, Trombino Sonia

机构信息

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, 87036 Cosenza, Italy.

出版信息

Gels. 2021 Aug 29;7(3):130. doi: 10.3390/gels7030130.

DOI:10.3390/gels7030130
PMID:34563016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8482217/
Abstract

The most common route of administration of ophthalmic drugs is the topical route because it is convenient, non-invasive, and accessible to all patients. Unfortunately, drugs administered topically are not able to reach effective concentrations. Moreover, their bioavailability must be improved to decrease the frequency of administrations and their side effects, and to increase their therapeutic efficiency. For this purpose, in recent decades, particular attention has been given to the possibility of developing prolonged-release forms that are able to increase the precorneal residence time and decrease the loss of the drug due to tearing. Among these forms, gel-based materials have been studied as an ideal delivery system because they are an extremely versatile class with numerous prospective applications in ophthalmology. These materials are used in gel eye drops, in situ gelling formulations, intravitreal injections, and therapeutic contact lenses. This review is intended to describe gel-based materials and their main applications in ophthalmology.

摘要

眼科药物最常见的给药途径是局部给药,因为它方便、无创,所有患者都可采用。不幸的是,局部给药的药物无法达到有效浓度。此外,必须提高它们的生物利用度,以减少给药频率及其副作用,并提高其治疗效果。为此,近几十年来,人们特别关注开发能够延长角膜前停留时间并减少因流泪导致药物损失的缓释剂型的可能性。在这些剂型中,基于凝胶的材料已被研究作为一种理想的给药系统,因为它们是一类极其通用的材料,在眼科有众多潜在应用。这些材料用于凝胶眼药水、原位凝胶制剂、玻璃体内注射和治疗性隐形眼镜。本综述旨在描述基于凝胶的材料及其在眼科的主要应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/4da8b0a65d28/gels-07-00130-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/6233b039cb79/gels-07-00130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/351d62f6e961/gels-07-00130-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/b3596b2f4420/gels-07-00130-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/07c4aaf84d34/gels-07-00130-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/4da8b0a65d28/gels-07-00130-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/6233b039cb79/gels-07-00130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/351d62f6e961/gels-07-00130-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/b3596b2f4420/gels-07-00130-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/07c4aaf84d34/gels-07-00130-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7d/8482217/4da8b0a65d28/gels-07-00130-g005.jpg

相似文献

1
Gel-Based Materials for Ophthalmic Drug Delivery.用于眼科药物递送的凝胶基材料。
Gels. 2021 Aug 29;7(3):130. doi: 10.3390/gels7030130.
2
Hydrogels in ophthalmic applications.眼科应用中的水凝胶。
Eur J Pharm Biopharm. 2015 Sep;95(Pt B):227-38. doi: 10.1016/j.ejpb.2015.05.016. Epub 2015 May 29.
3
Ophthalmic gels: Past, present and future.眼科凝胶:过去、现在和未来。
Adv Drug Deliv Rev. 2018 Feb 15;126:113-126. doi: 10.1016/j.addr.2017.12.017. Epub 2017 Dec 27.
4
Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.用于抗生素治疗的眼科给药系统——综述
Pharmaceutics. 2018 Jan 13;10(1):10. doi: 10.3390/pharmaceutics10010010.
5
Ophthalmic drug delivery systems--recent advances.眼科药物递送系统——最新进展
Prog Retin Eye Res. 1998 Jan;17(1):33-58. doi: 10.1016/s1350-9462(97)00002-5.
6
Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.采用具有延长滞留时间的 Terminalia arjuna 树胶/藻酸盐原位凝胶系统进行眼部药物输送。
Int J Biol Macromol. 2020 Jun 1;152:1056-1067. doi: 10.1016/j.ijbiomac.2019.10.193. Epub 2019 Nov 18.
7
Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.基于结冷胶和羟乙基纤维素的新型原位凝胶眼用给药系统:创新的流变学特征、体外和体内证据表明具有延长的角膜前滞留时间。
Int J Pharm. 2020 Jan 25;574:118734. doi: 10.1016/j.ijpharm.2019.118734. Epub 2019 Nov 6.
8
Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review.用于新型隐形眼镜基眼用药物递送系统的聚合物水凝胶:综述
Cont Lens Anterior Eye. 2008 Apr;31(2):57-64. doi: 10.1016/j.clae.2007.09.002. Epub 2007 Oct 25.
9
Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases.基于水凝胶的眼科药物传递系统治疗眼部疾病。
Mater Sci Eng C Mater Biol Appl. 2021 Aug;127:112212. doi: 10.1016/j.msec.2021.112212. Epub 2021 May 29.
10
Strategies to prolong the residence time of drug delivery systems on ocular surface.延长药物传递系统在眼表面停留时间的策略。
Adv Colloid Interface Sci. 2021 Feb;288:102342. doi: 10.1016/j.cis.2020.102342. Epub 2020 Dec 13.

引用本文的文献

1
Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight.用新兴疗法挑战青光眼:针对视力“隐形窃贼”的进展概述
Front Med (Lausanne). 2025 Mar 26;12:1527319. doi: 10.3389/fmed.2025.1527319. eCollection 2025.
2
Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.用于局部皮肤癌治疗的药物再利用与纳米技术:转向靶向和协同抗肿瘤效应
ACS Pharmacol Transl Sci. 2025 Jan 23;8(2):308-338. doi: 10.1021/acsptsci.4c00679. eCollection 2025 Feb 14.
3
Eye of the future: Unlocking the potential utilization of hydrogels in intraocular lenses.

本文引用的文献

1
Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.一种新型局部眼用原位凝胶系统治疗眼部感染的实验设计、配方和体内评价。
PLoS One. 2021 Mar 19;16(3):e0248857. doi: 10.1371/journal.pone.0248857. eCollection 2021.
2
Advanced nanodelivery platforms for topical ophthalmic drug delivery.用于局部眼科药物递送的先进纳米递药系统。
Drug Discov Today. 2021 Jun;26(6):1437-1449. doi: 10.1016/j.drudis.2021.02.027. Epub 2021 Mar 6.
3
Hydroxypropyl methylcellulose: Physicochemical properties and ocular drug delivery formulations.
未来之眼:释放水凝胶在人工晶状体中的潜在应用
Bioeng Transl Med. 2024 Apr 23;9(5):e10664. doi: 10.1002/btm2.10664. eCollection 2024 Sep.
4
Formulation of Thermo-Sensitive In Situ Gels Loaded with Dual Spectrum Antibiotics of Azithromycin and Ofloxacin.载有阿奇霉素和氧氟沙星双光谱抗生素的热敏原位凝胶的制剂
Polymers (Basel). 2024 Oct 22;16(21):2954. doi: 10.3390/polym16212954.
5
Transforming Medicinal Oil into Advanced Gel: An Update on Advancements.将药用油转化为高级凝胶:进展更新
Gels. 2024 May 17;10(5):342. doi: 10.3390/gels10050342.
6
Advancements in Regenerative Hydrogels in Skin Wound Treatment: A Comprehensive Review.再生水凝胶在皮肤创伤治疗中的研究进展:全面综述。
Int J Mol Sci. 2024 Mar 29;25(7):3849. doi: 10.3390/ijms25073849.
7
Application of Poloxamer for In Situ Eye Drop Modeling by Enrichment with Propolis and Balsam Poplar Buds Phenolic Compounds.泊洛沙姆通过富集蜂胶和香脂杨芽酚类化合物用于原位滴眼剂建模的应用。
Gels. 2024 Feb 21;10(3):161. doi: 10.3390/gels10030161.
8
Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecks.眼部药物递送中辅料加工概述:迄今的机遇与瓶颈
Heliyon. 2023 Dec 23;10(1):e23810. doi: 10.1016/j.heliyon.2023.e23810. eCollection 2024 Jan 15.
9
Factors affecting on release of miconazole from ocular gel.影响咪康唑从眼用凝胶中释放的因素。
J Adv Pharm Technol Res. 2023 Oct-Dec;14(4):294-298. doi: 10.4103/japtr.japtr_91_23. Epub 2023 Oct 30.
10
QbD Design, Formulation, Optimization and Evaluation of Trans-Tympanic Reverse Gelatination Gel of Norfloxacin: Investigating Gene-Gene Interactions to Enhance Therapeutic Efficacy.诺氟沙星经鼓膜逆行凝胶化凝胶的质量源于设计(QbD)设计、处方、优化及评价:探究基因-基因相互作用以提高治疗效果
Gels. 2023 Aug 15;9(8):657. doi: 10.3390/gels9080657.
羟丙甲纤维素:理化性质与眼用药物传递制剂。
Eur J Pharm Sci. 2021 Apr 1;159:105736. doi: 10.1016/j.ejps.2021.105736. Epub 2021 Jan 28.
4
Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.盐酸多西环素长循环热敏原位凝胶眼用制剂的研制及评价。
Int J Pharm. 2020 Dec 15;591:120010. doi: 10.1016/j.ijpharm.2020.120010. Epub 2020 Oct 22.
5
Moxifloxacin-imprinted silicone-based hydrogels as contact lens materials for extended drug release.载有莫西沙星的硅胶基水凝胶作为接触镜材料以实现药物的长效释放。
Eur J Pharm Sci. 2021 Jan 1;156:105591. doi: 10.1016/j.ejps.2020.105591. Epub 2020 Oct 13.
6
Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study.含羧甲基纤维素和透明质酸的无防腐剂人工泪液治疗干眼病的安全性和有效性:一项随机、对照、多中心3个月研究。
Clin Ophthalmol. 2020 Oct 1;14:2951-2963. doi: 10.2147/OPTH.S256480. eCollection 2020.
7
Gelling hypotonic polymer solution for extended topical drug delivery to the eye.用于眼部延长局部药物递送的胶凝低渗聚合物溶液。
Nat Biomed Eng. 2020 Nov;4(11):1053-1062. doi: 10.1038/s41551-020-00606-8. Epub 2020 Sep 7.
8
Intravitreal hydrogels for sustained release of therapeutic proteins.眼内水凝胶用于治疗性蛋白的持续释放。
J Control Release. 2020 Oct 10;326:419-441. doi: 10.1016/j.jconrel.2020.07.031. Epub 2020 Jul 25.
9
Special Issue on Designing Hydrogels for Controlled Drug Delivery: Guest Editors' Introduction.用于控释给药的水凝胶设计特刊:客座编辑引言
Pharmaceutics. 2020 Jan 10;12(1):57. doi: 10.3390/pharmaceutics12010057.
10
Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.热敏原位凝胶与药物树脂复合物用于眼部给药的比较:体外药物释放和体内组织分布。
Int J Pharm. 2020 Mar 30;578:119184. doi: 10.1016/j.ijpharm.2020.119184. Epub 2020 Feb 26.